Evidence map›Paper›PMID 33001460›Full record

ArticleAllergy2021

Microbial and transcriptional differences elucidate atopic dermatitis heterogeneity across skin sites.

Noora Ottman, Mauricio Barrientos-Somarribas, Nanna Fyhrquist, Helen Alexander, Lukas Wisgrill, Peter Olah, Sophia Tsoka, Dario Greco, Francesca Levi-Schaffer, Vassili Soumelis and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Allergy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Melittin-Loaded FeInternational journal of nanomedicine · 2026
    Article
  6. Review
  7. Microenvironmental host-microbe interactions in chronic inflammatory skin diseases.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2024
    Review
  8. Skin microbiota: pathogenic roles and implications in atopic dermatitis.Frontiers in cellular and infection microbiology · 2024
    Review
  9. Novel insights into atopic dermatitis.The Journal of allergy and clinical immunology · 2023
    Review
  10. Nextcast: A software suite to analyse and model toxicogenomics data.Computational and structural biotechnology journal · 2022
    Article
  11. Review
  12. Review
  13. Review
  14. [Microbiome update: from hype to crystal ball and valuable therapeutic tool!]Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2021
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 8 countries.

Noora OttmanInstitute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Mauricio Barrientos-SomarribasDepartment of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
Nanna FyhrquistInstitute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Helen AlexanderSt John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Lukas WisgrillDivision of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-9833-9499
Peter OlahDepartment of Dermatology, University Hospital Duesseldorf, Duesseldorf, Germany.
Sophia TsokaDepartment of Informatics, Faculty of Natural and Mathematical Sciences, King's College London, London, UK.
Dario GrecoFaculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Francesca Levi-SchafferPharmacology Unit, School of Pharmacy, Faculty of Medicine, The Institute for Drug Research, The Hebrew University of Jerusalem, Jerusalem, Israel.
Vassili SoumelisInstitut Curie, Paris, France.
Jens M SchröderDepartment of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany.
Juha KereDepartment of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.
Frank O NestleCutaneous Medicine Unit, St. John's Institute of Dermatology and Biomedical Research Centre, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Jonathan BarkerSt John's Institute of Dermatology, Division of Genetics and Molecular Medicine, Faculty of Life Sciences and Medicine, Kings College London, London, UK.
Annamari RankiDepartment of Dermatology, Allergology and Venereology, Inflammation Centre, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Antti LauermaDepartment of Dermatology, Allergology and Venereology, Inflammation Centre, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Bernhard HomeyDepartment of Dermatology, University Hospital Duesseldorf, Duesseldorf, Germany.
Björn AnderssonDepartment of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
Harri AleniusInstitute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-0106-8923
King's College London · GBUniversity of Helsinki · FIKarolinska Institutet · SEDüsseldorf University Hospital · DEHebrew University of Jerusalem · ILInserm · FRMedical University of Vienna · ATUniversity Hospital Schleswig-Holstein · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is well established that different sites in healthy human skin are colonized by distinct microbial communities due to different physiological conditions. However, few studies have explored microbial heterogeneity between skin sites in diseased skin, such as atopic dermatitis (AD) lesions. To address this issue, we carried out deep analysis of the microbiome and transcriptome in the skin of a large cohort of AD patients and healthy volunteers, comparing two physiologically different sites: upper back and posterior thigh. Microbiome samples and biopsies were obtained from both lesional and nonlesional skin to identify changes related to the disease process. Transcriptome analysis revealed distinct disease-related gene expression profiles depending on anatomical location, with keratinization dominating the transcriptomic signatures in posterior thigh, and lipid metabolism in the upper back. Moreover, we show that relative abundance of Staphylococcus aureus is associated with disease severity in the posterior thigh, but not in the upper back. Our results suggest that AD may select for similar microbes in different anatomical locations-an "AD-like microbiome," but distinct microbial dynamics can still be observed when comparing posterior thigh to upper back. This study highlights the importance of considering the variability across skin sites when studying the development of skin inflammation.

Indexed as

Dermatitis, AtopicEczemaMicrobiotaHumansSkinStaphylococcus aureusatopic dermatitisinflammationmicrobiome

Identifiers

PMID33001460
PMCPMC8246754
OpenAlexW3089708491

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.